Pulmonx
LUNG | NASDAQ
$2.80
-$0.06 (-2.10%)
At close: Nov 16, 2026, 4:00 PM ET
$2.80
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:15 PM ET
-2.10%
(1D)No price chart data available for 1D timeframe.
Rating
42.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #459/1021 (Top 45%)
Key Statistics
Market Data
Market Cap $121.94M
1D Range
2.69 2.90
52W Range
1.17 3.17
Valuation (TTM)
PE -2.80
PB 3.57
EV/EBITDA -3.41
Valuation (NTM)
Forward PE N/A
Forward PEG 0.08
Price Target $5.00
Cash Flow
FCF Yield -25.1%
SBC Adj. FCF Yield -32.4%
SBC Impact -28.9%
Margins
Gross Margin 77.4%
Operating Margin -44.4%
FCF Margin -34.5%
Growth (CAGR)
Revenue 3Y | 5Y 11.1% |
14.8%
Dil EPS 3Y | 5Y 18.2% |
9.3%
FCF 3Y | 5Y 8.5% |
11.4%
Returns
ROA -38.6%
ROE -98.2%
ROIC -43.3%
Financial Health
Net Debt
$3.66M
Current Ratio 4.05
Interest Coverage -9.39
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offerin...
Sector Healthcare
Industry Medical - Devices
Employees 296
IPO Date Oct 1, 2020
Website pulmonx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 27, 2026
EPS
-$0.19
Beat +25.96%
YoY:
+44.12% REV
$22.84M
Beat +4.11%
YoY:
+6.20%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$5.00
Upside
+78.57%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove LUNG